[ACRX] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
12-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- -2,159.31%
YoY- -177.76%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 740 6,435 1,730 226 27,607 1,675 624 2.87%
PBT -10,588 -9,682 -10,558 -13,818 17,769 -33,363 -20,101 -10.12%
Tax -703 68 -12 -1,218 -1,742 -22,841 -13,728 -39.03%
NP -9,885 -9,682 -10,546 -13,818 17,769 -10,522 -6,372 7.58%
Tax Rate - - - - 9.80% - - -
Total Cost 10,625 16,117 12,276 14,044 9,838 12,197 6,996 7.20%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -1,335.81 -150.46 -609.60 -6,114.16 64.36 -628.18 -1,021.15 4.57%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -3.88 -4.27 -4.66 -6.30 8.20 -5.67 -6.50 -8.23%
EPS Diluted -3.88 -4.27 -4.66 -6.22 8.20 -5.67 -6.50 -8.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.